SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-059604
Filing Date
2020-05-11
Accepted
2020-05-11 16:45:07
Documents
79
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014496-1_10q.htm 10-Q 977808
2 EXHIBIT 31.1 tm2014496d1_ex31-1.htm EX-31.1 9997
3 EXHIBIT 31.2 tm2014496d1_ex31-2.htm EX-31.2 10290
4 EXHIBIT 32.1 tm2014496d1_ex32-1.htm EX-32.1 3927
5 EXHIBIT 32.2 tm2014496d1_ex32-2.htm EX-32.2 4221
  Complete submission text file 0001104659-20-059604.txt   6843251

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stml-20200331.xml EX-101.INS 1827951
7 XBRL TAXONOMY EXTENSION SCHEMA stml-20200331.xsd EX-101.SCH 58634
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stml-20200331_cal.xml EX-101.CAL 65734
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stml-20200331_def.xml EX-101.DEF 175764
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE stml-20200331_lab.xml EX-101.LAB 513092
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stml-20200331_pre.xml EX-101.PRE 347767
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35619 | Film No.: 20865606
SIC: 2834 Pharmaceutical Preparations